Literature DB >> 20114128

Anxiety and mood disorders in narcolepsy: a case-control study.

H A Droogleever Fortuyn1, Martijn A Lappenschaar, Joop W Furer, Paul P Hodiamont, Cees A Th Rijnders, Willy O Renier, Jan K Buitelaar, Sebastiaan Overeem.   

Abstract

INTRODUCTION: Narcolepsy is a primary sleeping disorder with excessive daytime sleepiness and cataplexy as core symptoms. There is increasing interest in the psychiatric phenotype of narcolepsy. Although many authors suggest an overrepresentation of mood disorders, few systematic studies have been performed and conflicting results have been reported. Anxiety disorders in narcolepsy have only received little attention.
METHODS: We performed a case-control study in 60 narcolepsy patients and 120 age- and sex-matched controls from a previous population study. The Schedules for Clinical Assessment in Neuropsychiatry were used to assess symptoms and diagnostic classifications of mood and anxiety disorders.
RESULTS: Symptoms of mood disorders were reported by about one third of patients. However, the prevalence of formal mood disorder diagnoses - including major depression - was not increased. In contrast, more than half of the narcolepsy patients had anxiety or panic attacks. Thirty-five percent of the patients could be diagnosed with anxiety disorder (odds ratio=15.6), with social phobia being the most important diagnosis. There was no influence of age, sex, duration of illness or medication use on the prevalence of mood or anxiety symptoms and disorders. DISCUSSION: Anxiety disorders, especially panic attacks and social phobias, often affect patients with narcolepsy. Although symptoms of mood disorders are present in many patients, the prevalence of major depression is not increased. Anxiety and mood symptoms could be secondary complications of the chronic symptoms of narcolepsy. Recent studies have shown that narcolepsy is caused by defective hypocretin signaling. As hypocretin neurotransmission is also involved in stress regulation and addiction, this raises the possibility that mood and anxiety symptoms are primary disease phenomena in narcolepsy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20114128     DOI: 10.1016/j.genhosppsych.2009.08.007

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  25 in total

Review 1.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

2.  Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Authors:  Francesca Letizia Rocca; Elena Finotti; Fabio Pizza; Francesca Ingravallo; Michela Gatta; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

3.  Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy.

Authors:  Kiran Maski; Erin Steinhart; David Williams; Thomas Scammell; Julie Flygare; Kimberly McCleary; Monica Gow
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

4.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

5.  Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus.

Authors:  Widya Adidharma; Sean P Deats; Tomoko Ikeno; Jack W Lipton; Joseph S Lonstein; Lily Yan
Journal:  Horm Behav       Date:  2019-08-31       Impact factor: 3.587

6.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

7.  Increased mortality in narcolepsy.

Authors:  Maurice M Ohayon; Jed Black; Chinglin Lai; Mark Eller; Diane Guinta; Arun Bhattacharyya
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

8.  Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.

Authors:  S P Deats; W Adidharma; J S Lonstein; L Yan
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

Review 9.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

Review 10.  Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.

Authors:  Shi-Bin Li; Jeff R Jones; Luis de Lecea
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.